ASX:MDC Medlab Clinical (MDC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Medlab Clinical Stock (ASX:MDC) 30 days 90 days 365 days Advanced Chart Get Medlab Clinical alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume36,677 shsAverage VolumeN/AMarket Capitalization$15.07 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMedlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia. Its drug candidate includes NanaBis, a buccal spray from cannabis oil extract for oncology and pain management; and NanoCBD, a buccal spray from hemp oil extract for mental health. The company also develops NanoCelle, a patented sub-micron drug delivery platform that allows passive diffusion of active pharmaceutical ingredients directly into the bloodstream through oral-buccal, sublingual, intranasal, and transdermal or topical delivery. In addition, it offers virtual clinic services. The company was founded in 2012 and is headquartered in Botany, Australia.Read More… Receive MDC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medlab Clinical and its competitors with MarketBeat's FREE daily newsletter. Email Address MDC Stock News HeadlinesMedlab Clinical to be Delisted from ASXFebruary 27, 2025 | tipranks.comMedlab Clinical Reports Q2 2025 Financials Amidst Strategic ChangesFebruary 2, 2025 | tipranks.comGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.May 25, 2025 | Premier Gold Co (Ad)Medlab Clinical Faces Steep Revenue Decline and LossNovember 3, 2024 | markets.businessinsider.comChild Care on College Campuses: What to KnowOctober 24, 2024 | usnews.comMedlab West Africa - the Biggest Medical Lab Event in the Region Returns to LagosApril 16, 2024 | msn.comClinical Laboratory Technician SalaryMay 20, 2023 | money.usnews.comHealthKick Podcast: Aussie Bio Tech Medlab is confident in highly anticipated Phase III trialFebruary 13, 2023 | msn.comSee More Headlines MDC Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Medlab Clinical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medlab Clinical investors own include Magellan Financial Group (MFG), iSignthis (ISX), FBR (FBR), Embark Early Education (EVO), Dacian Gold (DCN), Constellation Technologies (CT1) and Bod Australia (BDA). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryConstruction Current SymbolASX:MDC CIKN/A Webwww.medlab.co Phone61 2 8188 0311FaxN/AEmployees1,640Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($547.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,940,000.00 Net Margins-1,351.41% Pretax MarginN/A Return on Equity12,575.02% Return on Assets-79.67% Debt Debt-to-Equity RatioN/A Current Ratio0.35 Quick Ratio3.71 Sales & Book Value Annual Sales$-1,470,000.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow5.12 Book ValueA($0.31) per share Price / BookN/AMiscellaneous Outstanding Shares2,280,000Free FloatN/AMarket Cap$15.07 million OptionableNot Optionable Beta0.89 20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free Report This page (ASX:MDC) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medlab Clinical Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Medlab Clinical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
